Funding
Accelerator investment · Enterprise software

Amytis secures £60,000 from BGV for its life science research workspace

Bethnal Green Ventures backs Amytis through its Autumn 2025 Tech for Good programme, combining equity investment with six weeks of founder support.

By RoundOS Funding desk

Amytis secured £60,000 from Bethnal Green Ventures through its Autumn 2025 Tech for Good programme. The investor announced the company’s addition to its portfolio on September 8, 2025. The programme provides the investment in return for a 7% equity stake, alongside six weeks of founder support and mentorship.

Amytis is developing a digital workspace that connects experiments, protocols, literature and data in a shared research graph. It aims to make AI and data modelling tools accessible to life science teams without requiring coding expertise.

Funding history

Accelerator investment · This round£60K

Sources

  1. Meet our Autumn 2025 cohortbethnalgreenventures.com · Sep 8, 2025
  2. Apply for the BGV Autumn 2025 Tech for Good Programmebethnalgreenventures.com · May 1, 2025
  3. Amytisamytis.io

Similar rounds

All Enterprise software rounds →
Biograil

Biograil develops oral capsules designed to deliver biologic medicines through the stomach wall, offering an alternative route for treatments given by injection.

€20MFinancing round · Nov 4, 2026
bit.bio

Creates functional, human-relevant cells and models for research, drug discovery, and development

$25MSeries D · Nov 4, 2026
Transtreams Technology

Transtreams Technology develops video-processing chips and AI hardware for cloud platforms and edge-computing applications.

CN¥1BSeries B · Nov 4, 2026
Supa

Supa acquires local property management firms and equips their teams with technology for maintenance, service charges and building compliance.

£21MSeed financing combining equity and debt · Nov 4, 2026

Related